中文产业新闻评分65Chinese source
君赛生物诺吉仑赛注射液拟纳入CDE优先审评,治疗经治转移性黑色素瘤
国内首个TIL疗法拟纳入优先审评
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
国内首个TIL疗法拟纳入优先审评
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.